2017
DOI: 10.1097/md.0000000000005718
|View full text |Cite
|
Sign up to set email alerts
|

Tranexamic acid reduces perioperative blood loss of posterior lumbar surgery for stenosis or spondylolisthesis

Abstract: Background:A prospective, randomized, double-blind, placebo-controlled study was performed. The routine usage of TA in spinal surgery is controversial. Only a few studies have focused on patients undergoing posterior lumbar surgery for stenosis or spondylolisthesis, although a large clinical cohort exists in the population. This study aimed to evaluate the effect and safety of TA in reducing perioperative blood loss in posterior lumbar surgery for stenosis or spondylolisthesis.Methods:100 eligible patients out… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

2
37
1
1

Year Published

2017
2017
2020
2020

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 47 publications
(41 citation statements)
references
References 29 publications
2
37
1
1
Order By: Relevance
“…The intravenous application of TXA has been confirmed as effectively decreasing blood loss and transfusion requirement in spinal surgery [ 6 , 7 ]. Recently, topical TXA is widely established in hip and knee arthroplasty and successfully reduced postoperative blood loss and blood transfusion requirements [ 17 , 18 ].…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…The intravenous application of TXA has been confirmed as effectively decreasing blood loss and transfusion requirement in spinal surgery [ 6 , 7 ]. Recently, topical TXA is widely established in hip and knee arthroplasty and successfully reduced postoperative blood loss and blood transfusion requirements [ 17 , 18 ].…”
Section: Discussionmentioning
confidence: 99%
“…Tranexamic acid (TXA), an antifibrinolytic drug, competitively blocks the lysine-binding site of plasminogen and has been used to reduce blood loss in spine surgery for many years [ 5 ]. Various studies have reported that intravenous application of TXA reduces blood loss and allogenic blood transfusions in spinal surgery without increasing related complications [ 6 8 ]. In theory, there remains an unresolved concern about the potential thrombogenicity of intravenous TXA [ 9 ].…”
Section: Introductionmentioning
confidence: 99%
“…As for TXA, Shi performed a prospective, randomized, double-blind, placebo-controlled study, in which the eligible patients were randomized to receive either a bolus dose of 30 mg/kg intravenous TXA, a maintenance dosage of 2 mg/kg/h TXA, or an equivalent volume of normal saline. The result showed that the blood transfusion rates did not vary significantly [ 17 ]. In our study, the amount of allogeneic blood transfusion of experimental groups was only 1/4 of the control group; meanwhile, there were no differences between collagen sponge group and topical TXA group.…”
Section: Discussionmentioning
confidence: 99%
“…However, intravenous TXA may have potentially adverse effects on patients, including DVT, PE, and myocardial infarction [18,19]. Intravenous TXA is usually avoided in patients with a previous history of myocardial infarction, DVT/ PE, stroke, and seizure disorders [20][21][22][23]. In addition, some research teams had published different conclusions.…”
Section: Postoperative Aptt (Seconds)mentioning
confidence: 99%